Bellamy P E, Oye R K
Crit Care Med. 1984 Aug;12(8):622-5.
We reviewed the hospital charges, underlying diagnoses, and hospital outcomes in 39 patients with adult respiratory distress syndrome (ARDS) admitted to the respiratory ICU of a university hospital between July 1979 and June 1981. Charges per patient ranged from $9263 to $187,893 with a median of $52,894. Median ICU charges were $2430/day. Only 7 patients survived their hospitalization. Compared to nonsurvivors, survivors had longer ICU and hospital stays but lower daily ICU charges ($1683 vs. $2760,p = .001). Only 1 of 27 patients with underlying hematologic/oncologic diseases survived, compared to 6 of 12 patients with other underlying diseases. Charges and outcomes in this study reflect the underlying patient population and philosophy of care at the study institution. Considering the high costs and poor outcomes in ARDS patients with underlying hematologic/oncologic problems, we recommend that the appropriateness of aggressive treatment be reconsidered.
我们回顾了1979年7月至1981年6月期间入住一所大学医院呼吸重症监护病房(ICU)的39例成人呼吸窘迫综合征(ARDS)患者的医院收费、基础诊断及住院结局。每位患者的费用从9263美元到187,893美元不等,中位数为52,894美元。ICU收费中位数为每天2430美元。只有7例患者存活出院。与未存活者相比,存活者在ICU和住院时间更长,但每日ICU费用更低(1683美元对2760美元,p = 0.001)。27例患有基础血液学/肿瘤学疾病的患者中只有1例存活,而12例患有其他基础疾病的患者中有6例存活。本研究中的收费和结局反映了研究机构的基础患者群体及治疗理念。考虑到患有基础血液学/肿瘤学问题的ARDS患者成本高昂且结局不佳,我们建议重新考虑积极治疗的合理性。